Metformin and its derivatives in breast cancer: from glycaemic control to tumor-intrinsic pathways
{{output}}
Background: Breast cancer (BC) remains the most commonly diagnosed malignancy among women worldwide, with metabolic dysregulation of glucose and hyperinsulinemia increasingly recognised as contributors to its development and prog... ...
